Patents by Inventor Malini Viswanathan

Malini Viswanathan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human neonatal Fc receptor antibodies and methods of use thereof
    Patent number: 9359438
    Abstract: The disclosure relates to antibodies that bind FcRn and methods of using these antibodies.
    Type: Grant
    Filed: June 1, 2012
    Date of Patent: June 7, 2016
    Assignee: DYAX CORPORATION
    Inventors: Daniel J. Sexton, Christopher Tenhoor, Malini Viswanathan
  • PLASMA KALLIKREIN BINDING PROTEINS
    Publication number: 20160102150
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Application
    Filed: December 15, 2015
    Publication date: April 14, 2016
    Applicant: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • Method of treating hereditary angioedema using plasma kallikrein binding antibodies
    Patent number: 9266964
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Grant
    Filed: June 20, 2014
    Date of Patent: February 23, 2016
    Assignee: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • Antibodies to FeRn and uses thereof
    Patent number: 9260520
    Abstract: This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.
    Type: Grant
    Filed: January 30, 2014
    Date of Patent: February 16, 2016
    Assignees: DYAX CORP., BIOGEN HEMOPHILIA INC.
    Inventors: Christopher TenHoor, Arumugam Muruganandam, Robert Charles Ladner, Clive Wood, Alan J. Bitonti, James McGivney, Kevin McDonnell, Liming Liu, Jennifer Dumont, Aaron K. Sato, Malini Viswanathan
  • COLLAGEN 7 AND RELATED METHODS
    Publication number: 20150011733
    Abstract: Disclosed are methods of making collagen 7, or functional fragments thereof, as well as collagen 7, and functional fragments thereof produced by such methods, nucleic acids encoding collagen 7, and functional fragments thereof, as well as vectors and host cells comprising such nucleic acids.
    Type: Application
    Filed: August 3, 2012
    Publication date: January 8, 2015
    Inventors: Malini Viswanathan, Mark DeSouza
  • PLASMA KALLIKREIN BINDING PROTEINS
    Publication number: 20140335023
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Application
    Filed: July 23, 2014
    Publication date: November 13, 2014
    Applicant: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • FC RECEPTOR BINDING PROTEINS
    Publication number: 20140308206
    Abstract: The disclosure relates to antibodies that bind FcRn and methods of using these antibodies.
    Type: Application
    Filed: June 1, 2012
    Publication date: October 16, 2014
    Applicant: DYAX CORP.
    Inventors: Daniel J. Sexton, Christopher Tenhoor, Malini Viswanathan
  • PLASMA KALLIKREIN BINDING PROTEINS
    Publication number: 20140302048
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Application
    Filed: June 20, 2014
    Publication date: October 9, 2014
    Applicant: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • FC RECEPTOR BINDING PROTEINS
    Publication number: 20140248287
    Abstract: This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.
    Type: Application
    Filed: January 30, 2014
    Publication date: September 4, 2014
    Applicants: SYNTONIX PHARMACEUTICALS, INC., DYAX CORP.
    Inventors: Christopher TenHoor, Arumugam Muruganandam, Robert Charles Ladner, Clive Wood, Alan J. Bitonti, James Stattel, Kevin McDonnell, Liming Liu, Jennifer Dumont, Aaron K. Sato, Malini Viswanathan
  • Plasma kallikrein binding proteins
    Patent number: 8822653
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Grant
    Filed: January 6, 2011
    Date of Patent: September 2, 2014
    Assignee: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • Plasma kallikrein binding proteins
    Patent number: 8816055
    Abstract: Plasma kallikrein binding proteins and methods of using such proteins are described.
    Type: Grant
    Filed: January 6, 2012
    Date of Patent: August 26, 2014
    Assignee: Dyax Corp.
    Inventors: Daniel J. Sexton, Malini Viswanathan
  • Fc receptor binding proteins
    Patent number: 8815246
    Abstract: This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: August 26, 2014
    Assignees: Dyax Corp., Syntonix Pharmaceuticals, Inc.
    Inventors: Christopher TenHoor, Arumugam Muruganandam, Robert Charles Ladner, Clive Wood, Alan J. Bitonti, James Stattel, Kevin McDonnell, Liming Liu, Jennifer Dumont, Aaron K. Sato, Malini Viswanathan
  • FC RECEPTOR BINDING PROTEINS
    Publication number: 20130078262
    Abstract: This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.
    Type: Application
    Filed: September 14, 2012
    Publication date: March 28, 2013
    Applicant: Dyax Corp.
    Inventors: Christopher TenHoor, Arumugam Muruganandam, Robert Charles Ladner, Clive Wood, Alan J. Bitonti, James Stattel, Kevin McDonnell, Liming Liu, Jennifer Dumont, Aaron Sato, Malini Viswanathan
  • FC RECEPTOR BINDING PROTEINS
    Publication number: 20130045218
    Abstract: This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.
    Type: Application
    Filed: August 13, 2012
    Publication date: February 21, 2013
    Applicants: Syntonix Pharmaceuticals, Inc., Dyax Corp.
    Inventors: Christopher TenHoor, Arumugam Muruganandam, Robert Charles Ladner, Clive Wood, Alan J. Bitonti, James Stattel, Kevin McDonnell, Liming Liu, Jennifer Dumont, Aaron Sato, Malini Viswanathan